Clinical Research Directory
Browse clinical research sites, groups, and studies.
Diffuse Optical Monitoring With Inhaled Nitric Oxide
Sponsor: Steven Messe
Summary
This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are continuously monitored.
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2017-04-04
Completion Date
2026-07
Last Updated
2025-08-24
Healthy Volunteers
Yes
Conditions
Interventions
Nitric Oxide
Inhaled Nitric Oxide gas
Locations (1)
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States